Mahamaya Lifesc. — 360° view

Mahamaya Lifesc, a company in the Pesticides & Agrochemicals industry, reported revenue of ₹212 crore and net profit of ₹12 crore for the September 2026 quarter.

Mahamaya Lifesc. (BSE: MAHALIFE) closed at ₹147.60 on 20 Nov 2026, up 26.7% over the past year. Its market capitalisation is ₹345 crore and it trades at 17.5 times earnings.

Share price
₹147.60 (20 Nov 2026)
Market cap
₹345 Cr (20 Nov 2026)
P/E
17.54 (20 Nov 2026)
Revenue
₹212 Cr (September 2026 quarter)
Net profit
₹12 Cr (September 2026 quarter)
ROCE
20.0% (FY26)
ROE
19.3% (FY26)
Book value
₹57.0 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹205.05 / ₹111.20 (20 Nov 2026)
1-year return
26.7% (to 20 Nov 2026)
Sector
Commodities
Industry
Pesticides & Agrochemicals
Symbol
BSE: MAHALIFE

ncorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.